A 10% liquid immunoglobulin preparation for intravenous use (Privigen®) in paediatric patients with primary immunodeficiencies and hypersensitivity to IVIG-Reference-Cited by-同舟云学术

A 10% liquid immunoglobulin preparation for intravenous use (Privigen®) in paediatric patients with primary immunodeficiencies and hypersensitivity to IVIG

Published:2014-03 Issue:2 Volume:42 Page:136-141
ISSN:0301-0546
Container-title:Allergologia et Immunopathologia
language:en
Short-container-title:Allergologia et Immunopathologia

Author:

Lozano-Blasco J.,Martín-Mateos M.A.,Alsina L.,Domínguez O.,Giner M.T.,Piquer M.,Alvaro M.,Plaza A.M.

Publisher

Codon Publications

Subject

General Medicine,Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Reference30 articles.

1. Safety of IGIV therapy and infusion-related adverse events;Ballow;Immunol Res,2007

2. Plasma infusions in immunologic deficiency states: metabolic and therapeutic studies;Stiehm;Blood,1996

3. Use of intravenous gamma-globulin in antibody immunodeficiency: results of a multicenter controlled trial;Ammann;Clin Immunol Immunopathol,1982

4. The use of intravenous immune globulin in immunodeficiency diseases;Buckley;N Engl J Med,1991

5. Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease;Cunningham-Rundles;Ann Intern Med,1984

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world experience with CLAIRYG® 50 mg/mL (intravenous immunoglobulin) in children under 12 years with primary immunodeficiency or immmune thrombocytopenia: a post-approval safety study;Frontiers in Pediatrics;2023-10-02

2. Un protocolo de enfermería para la administración segura de inmunoglobulina intravenosa;Nursing (Ed. española);2018-03

3. Surveillance study on the tolerability and safety of Flebogamma®DIF (10% and 5% intravenous immunoglobulin) in adult and pediatric patients;Pharmacology Research & Perspectives;2017-08-25

4. A nursing protocol for safe IVIG administration;Nursing;2017-08

5. Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency;Journal of Clinical Immunology;2017-03-18